Abstract
A randomized clinical trial involving more than 300 patients has found no benefit from omega‐3 polyunsaturated fatty acids in conjunction with cognitive therapy in preventing onset of psychotic illness in at‐risk young adults. The trial, results of which were published online Nov. 23, 2016, in JAMA Psychiatry, failed to replicate results of an earlier study indicating that omega‐3s were superior to placebo in reducing the risk of transition to psychosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
